Latest Market Positioning News

8VI Holdings Limited has confirmed its voluntary delisting from the ASX, reporting a challenging quarter marked by declining cash reserves and a strategic pivot towards preventive care that is yet to yield significant revenue.

Phoslock Environmental Technologies reported a widening cashflow deficit and disappointing sales in the December 2024 quarter, while legal challenges and share suspension continue to cloud its outlook.

Gathid Ltd reports a strong quarter with a 92% year-on-year increase in Annual Recurring Revenue, new customer wins, and industry recognition, despite ongoing challenges in finalising the sale of its physical security business.

Income Asset Management delivered steady revenue of $4.0 million in Q2 FY2025 alongside significant growth in funds under administration and client accounts, while retiring $10 million in debt to reduce interest costs.

ECP Emerging Growth Limited has reported steady financial health and full compliance with its convertible notes obligations for the quarter ended December 2024, maintaining a conservative loan-to-value ratio and an unchanged conversion price.

Arrow Minerals Ltd has temporarily paused trading of its securities, signaling an imminent announcement that could influence its market position.

Southern Cross Gold Consolidated Ltd has completed its acquisition of Southern Cross Gold Ltd, issuing over 125 million shares and announcing key board changes. The move positions the company to advance the high-potential Sunday Creek Gold-Antimony Project amid a strengthened leadership team.

IDT Australia has finalized a $20 million asset-based loan facility with ScotPac, replacing its previous $4.7 million NAB facility, to support its expanding sales pipeline and recent contract wins.

Volt Resources Limited has successfully repaid a AU$500,000 loan to RiverFort Global Opportunities, underscoring its financial discipline amid ongoing graphite project developments.

AMCIL Limited posted a half-year profit of $3.6 million, down 12.6%, yet its portfolio outperformed the S&P/ASX 200 with an 8.7% return. The company declared a steady interim dividend amid cautious market conditions.

Sky Metals has reported strong trenching results at its Tallebung Tin Project, pinpointing four critical zones for bulk sampling and metallurgical testwork that promise to refine resource estimates and optimize production.

Paradigm Biopharmaceuticals has secured a $6.3 million R&D Tax Incentive refund, lifting its cash reserves to $31 million and reinforcing its push into Phase 3 osteoarthritis clinical trials.